Browsing "Trials"
Duragesic© — JNJ likely to lose to Mylan Labs
November 21, 2003 Introduction Johnson and Johnson sued Mylan Laboratories in Burlington, Vermont in a patent infringement lawsuit involving a [...]
Epogen 1: TKT’s Malpractice Weakens Defense
February 7, 2000 Previously, patent lawyers retained by Verdict believed that TKT’s patents did not appear to infringe on Amgen’s [...]
Epogen 2: summary judgement motions continued
March 31,2000 On March 27 & 28, Federal Judge WilliamYoung heard arguments on Amgen’s motions for summary judgement. The hearing [...]
Epogen 3: Only a Miracle Can Save TKT !
September 6, 2000 Prior History: Several years ago, a patent lawyer reviewed Amgen’s patents on erythropoietin (EPO) for Verdict, and [...]
Epogen 4: Appeals Court Confirms Amgen Win
January 7, 2003 Biotechnology company Amgen Inc. said on Monday an appeals court affirmed a district court decision that found [...]
Fosamax Weekly: Merck Retains Exclusivity until 2018
April 30, 2003 INTRODUCTION Merck’s patent infringement suit against Teva came to trial in Wilmington, Delaware from March 4 to [...]
Fosamax® Daily: Appeals Court Will Rule for Merck
June 3, 2003 INTRODUCTION On June 3, 2003, the Court of Appeals for the Federal Circuit heard oral argument in [...]
Fosmax Daily: Merck will retain exclusivity until 2007
May 16, 2002 Introduction. Teva and IVAX’s legal efforts to launch a generic osteoporosis drug to compete with Merck’s Fosamax [...]
Fosmax: Courts Uphold Merck’s Daily & Weekly patents
(BUSINESS WIRE)–Oct. 30, 2003 Oct. 30, 2003–Merck & Co., Inc. announced today that the U.S. Court of Appeals for the [...]
Lipitor Patents Upheld by Federal Trial Judge
December 16, 2005 A federal judge Friday upheld the validity of two key U.S. patents on Pfizer Inc.’s (PFE) Lipitor [...]
Related Case Type
